In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Andrew Mackinnon, senior vice president ...

Once we get those ideas kind of gelled together, we’ll get public engagement on all of those ideas,” Haibach said. “We can make up some boards and some nice graphic ...

Q3 2026 Earnings Call March 4, 2026 7:00 PM ESTCompany ParticipantsEric Schmiedchen - Head of Investor RelationsAlfred Felder ...

The shift is one of the most striking illustrations yet of how much the political tides have turned in favor of development, particularly on the left, as New York City struggles with a worsening ...

Shareholders of Orion Minerals Ltd (ASX/JSE: ORN) (Orion or the Company) are advised that the Company has today published its Interim Financial Report for the half year ended 31 December 2025 ...

Aggregating ‘negative’ immunotherapy trials can uncover reproducible immune perturbations that are missed in single studies, reframing lack of clinical benefit as potentially informative biologic ...

Ambiq Micro, Inc. (NYSE:AMBQ) Q4 2025 Earnings Call Transcript March 5, 2026 Ambiq Micro, Inc. beats earnings expectations. Reported EPS is $-0.32, expectations were $-0.39. Operator: Good morning, ...

Q4 2025 Earnings Call March 6, 2026 10:00 AM ESTCompany ParticipantsMaria Feller - Head of Investor RelationsFernando Bonnet ...

The year began on a high note when "Love Between Lines," a Chinese romance drama starring Chen Xing Xu and Lu Yu Xiao, ...

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...

From the new MacBook Air and upgraded MacBook Pro to the iPhone 17e, here are all the Apple announcements you might have missed.